Teresa Odorisio


Affiliation: Istituto Dermopatico dell'Immacolata
Country: Italy


  1. Cianfarani F, De Domenico E, Nyström A, Mastroeni S, Abeni D, Baldini E, et al. Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa. Matrix Biol. 2018;: pubmed publisher
    ..More generally, our data indicate that modifying extracellular matrix composition is an option to improve RDEB disease course. ..
  2. Odorisio T. Epigenetic Control of Skin Re-Epithelialization: the NF-kB/JMJD3 Connection. J Invest Dermatol. 2016;136:738-740 pubmed publisher
    ..sheds light on the role of histone demethylase Jumonji domain-containing protein D3 in promoting keratinocyte function after injury, and it links Jumonji domain-containing protein D3-dependent gene expression to NK-kB activity. ..
  3. Cianfarani F, Zambruno G, Castiglia D, Odorisio T. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa. Am J Pathol. 2017;187:1445-1453 pubmed publisher
    ..This review summarizes findings related to healing impairment in RDEB, and highlights therapeutic strategies for ameliorating healing. ..
  4. request reprint
    Odorisio T, Schietroma C, Zaccaria M, Cianfarani F, Tiveron C, Tatangelo L, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci. 2002;115:2559-67 pubmed